Skip to content
IonOpticks 通过与亚太、欧盟和美国市场的新分销合作伙伴建立合作关系,扩大全球业务范围

Melbourne, Australia – IonOpticks, developer of the highest-performing chromatography columns for mass spectrometry research, today announces a major expansion of its global distribution network, partnering with several leading scientific suppliers across APAC. The move builds on established partnerships in the United States, Europe and the United Kingdom, and will make the company’s renowned columns more accessible to researchers in regions where supply has historically been constrained by logistics, import duties, and extended delivery times.

For researchers in these markets, accessing high-performance liquid chromatography columns often means waiting weeks for international shipments, navigating complex customs procedures, and paying premium import costs. IonOpticks’ new partnerships aim to address these challenges by placing stock locally, cutting lead times from weeks to days, and ensuring support is available in-region and in-language.

That commitment to accessibility is shared by IonOpticks’ new distributor, SIG, in South Korea, who expressed their enthusiasm for the collaboration:

“We are delighted to partner with IonOpticks as their official distributor in South Korea. We believe this collaboration will bring great value to SIG’s customers and look forward to building a strong and lasting relationship. With seamless communication as our foundation, we are confident that we will create sustained and meaningful synergy across all our endeavours.”

Covering distribution in both Singapore and Malaysia, Lab Science Solution echoed this sentiment, highlighting the impact for researchers in their region:

“Through this partnership, we are committed to providing advanced separation solutions that enhance your mass spectrometry results and research outcomes. We look forward to the shared opportunities and success in the new partnership between Lab Science Solution and IonOpticks.”

Founded and manufacturing entirely in Australia, IonOpticks understands the obstacles researchers face when sourcing advanced scientific tools internationally. Aurora Series chromatography, renowned for delivering unmatched sensitivity, reproducibility, and durability in LC-MS workflows, has become the go-to solution for proteomics, biomarker and drug discovery, and other cutting-edge research disciplines. With these new agreements in place, the company can now ensure that the same performance scientists expect is delivered with the speed and service they deserve.

The expansion aligns with IonOpticks’ mission to elevate the standard of scientific enquiry by broadening the reach of world-class LC-MS tools and enabling more laboratories, regardless of geography, to pursue ambitious research goals.

“In proteomics and beyond, timing can be the difference between leading a discovery and missing it,” added Michael Sinden, Chief Brand Officer at IonOpticks. “With trusted local partners holding stock and providing immediate customer service and support, our users can keep their projects moving forward without delay.”

— ENDS —

Media Contact:

Michael Sinden, CBO (communications@ionoptickscopy.com)


The newly appointed distribution partners are:

APAC

EU and United Kingdom

United States

Share:

Related publications & news

FOR IMMEDIATE RELEASE Melbourne, Australia – 05 November, 2025 – IonOpt...
Karl Krull is taking single-cell proteomics
Dr. Karl Krull, a proteomics researcher working in Jeroen Krijgsveld‘...
IN THIS EDITION: Big things are happening at IonOpticks. We’re excited to...
Dr. Patricia Skowronek, a postdoctoral researcher working with Prof. Matthi...
Credit: Modified version of an image by Elham Karimi and Simon Milette, Wal...
An industry-focused top-down mass spectrometry (TDMS) platform for resolvin...
IonOpticks, a leading global producer of high-performance chromatography co...
Overall workflows and numbers of proteins identified from various methods. ...
Previous
Next